Fischer Medical Ventures Limited (NSE:FISCHER)
41.00
-0.17 (-0.41%)
Apr 2, 2026, 3:30 PM IST
Fischer Medical Ventures Market Cap
Fischer Medical Ventures has a market cap or net worth of 26.67 billion as of April 2, 2026. Its market cap has decreased by -47.97% in one year.
Market Cap
26.67B
Enterprise Value
26.62B
Revenue
2.60B
Ranking
n/a
PE Ratio
67.61
Stock Price
41.00
Market Cap Chart
Since June 8, 2005, Fischer Medical Ventures's market cap has increased from 49.88M to 26.67B, an increase of 53,375.22%. That is a compound annual growth rate of 35.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 26.67B | -1.84% |
| Dec 31, 2025 | 27.17B | -27.86% |
| Dec 31, 2024 | 37.67B | 6,473.59% |
| Dec 29, 2023 | 573.00M | 3,239.74% |
| Dec 30, 2022 | 17.16M | 6.06% |
| Dec 31, 2021 | 16.18M | 167.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 1.58T |
| Apollo Hospitals Enterprise | 1.07T |
| Cipla | 988.89B |
| Indraprastha Medical Corporation | 34.13B |
| Artemis Medicare Services | 32.53B |
| RPG Life Sciences | 30.72B |
| Orchid Pharma | 24.47B |